| |
| |
|
| Insider
Information: |
Schafer Gregory W |
| Relationship: |
Chief Operating Officer |
| City: |
Concord |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
263,909 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,261,594 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
263,909 |
|
|
| Total
Value |
$10,261,594 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
CFO |
2008-09-18 |
9,747 |
2007-03-30 |
0 |
Premium* |
|
|
Capricor Therapeutics |
CAPR |
Director |
2008-04-15 |
100 |
2008-04-15 |
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
Chief Operating Officer |
2018-01-25 |
254,062 |
2015-04-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-01-25 |
4 |
OE |
$0.01 |
$33 |
D/D |
3,317 |
254,062 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-01-25 |
4 |
OE |
$0.82 |
$49,200 |
D/D |
60,000 |
250,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-01-02 |
4 |
AS |
$7.61 |
$152,142 |
D/D |
(20,000) |
190,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-01-02 |
4 |
OE |
$0.82 |
$20,767 |
D/D |
20,000 |
210,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-12-29 |
4 |
OE |
$0.82 |
$34,440 |
D/D |
42,000 |
190,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-12-01 |
4 |
OE |
$0.82 |
$20,767 |
D/D |
20,000 |
168,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-12-01 |
4 |
AS |
$9.34 |
$186,882 |
D/D |
(20,000) |
148,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-11-06 |
4 |
AS |
$7.97 |
$159,312 |
D/D |
(20,000) |
148,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-11-06 |
4 |
OE |
$0.82 |
$20,767 |
D/D |
20,000 |
168,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-10-02 |
4 |
AS |
$10.75 |
$215,060 |
D/D |
(20,000) |
148,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-10-02 |
4 |
OE |
$0.82 |
$27,148 |
D/D |
20,000 |
168,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-09-13 |
4 |
S |
$10.99 |
$53,380 |
D/D |
(4,859) |
148,745 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
32,625 |
153,604 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-09-01 |
4 |
AS |
$11.70 |
$233,980 |
D/D |
(20,000) |
120,979 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-09-01 |
4 |
OE |
$1.00 |
$24,800 |
D/D |
20,000 |
140,979 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-08-08 |
4 |
AS |
$12.16 |
$172,550 |
D/D |
(14,189) |
120,979 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-08-08 |
4 |
OE |
$1.00 |
$18,004 |
D/D |
14,189 |
135,168 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-08-07 |
4 |
OE |
$1.00 |
$31,616 |
D/D |
25,811 |
146,790 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-08-07 |
4 |
AS |
$12.17 |
$314,233 |
D/D |
(25,811) |
120,979 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-06-28 |
4 |
AS |
$11.26 |
$450,568 |
D/D |
(40,000) |
120,979 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-06-28 |
4 |
OE |
$1.45 |
$58,000 |
D/D |
40,000 |
160,979 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-12-23 |
4 |
OE |
$0.82 |
$28,700 |
D/D |
35,000 |
120,979 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-11-11 |
4 |
AS |
$14.86 |
$448,033 |
D/D |
(30,144) |
85,979 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-11-11 |
4 |
OE |
$1.45 |
$43,709 |
D/D |
30,144 |
116,123 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-11-10 |
4 |
AS |
$14.74 |
$734,698 |
D/D |
(49,856) |
85,979 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
